ADVANCEMENT IN TREATMENT TECHNOLOGY FOR UTERINE LEIOMYOMA

Abstract

Uterine leiomyomass, or fibroids, represent a major public health problem.This is most common female pelvic tumor, typically reported to occur in 20–40% of reproductive aged women, and up to 70% of white and 80% of black women by the age of 50 years Most fibroids are a symptomatic, but nearly half of women with fibroids have significant and often disabling symptoms including heavy menstrual bleeding, pain and pressure symptoms Traditionally, symptomatic fibroids have been treated with myomectomy or hysterectomy performed by laparotomy In an effort to reduce the cost, morbidity and lifestyle impact of major surgery, various less invasive or non-surgical procedures, new treatment approaches have become available to women with symptomatic fibroids. Undoubtedly the most significant therapeutic innovation has been the advent of uterine artery emobilization (UAE) as a form of non-surgical management. New technology has provided additional minimally invasive options such as percutaneous laser ablation, cryoablation, transvaginal uterine artery occlusion and magnetic resonance imaging (MRI)-guided focused ultrasound that are currently under intense investigation. Furthermore, new medications have been introduced, that show for practical, long-term medical therapy for symptomatic fibroids.

Authors and Affiliations

Ruby Rohilla , Jitender Madan , Gaurav Kumar

Keywords

Related Articles

SELF MICRO EMULSIFYING DRUG DELIVERY SYSTEM

Oral route has always been preferred route for formulators and has dominated over other routes of administrations. However this preferred route is limited to those drugs molecule that are permeable across the gastric m...

SIMULTANEOUS ESTIMATION OF NEBIVOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE IN BULK AND IN A TABLET DOSAGE FORM BY MULTICOMPONENT AND SIMULTANEOUS ESTIMATION METHOD

Novel, simple, sensitive, rapid, accurate and economical spectrophotometric methods have been developed for simultaneous estimation of Nebivolol Hydrochloride and Hydrochlorothiazide. These methods involve solving of s...

COMPOSITION AND STABILITY OF CHROMIUM METAL COMPLEXES WITH DRUG SALBUTAMOL AND AMINO ACIDS

The equillibrium studies of the mixed ligand complexes of chromium (III) ion with drug salbutamol as primary ligand and the amino acids viz. glycine, arginine, tryptophan, leucine, glutamic acid, glutamine, valine, met...

Safety of tolfenamic acid following repeated Intramuscular administration in wistar rats.

Tolfenamic acid (TA) is a non-steroidal anti-inflammatory agent of the fenamate sub-group. Safety of Tolfenamic acid (4 mg/kg) after daily intramuscular administration for 14 days was evaluated in wistar rats. Repeated...

EVALUATION OF POLYHERBAL FORMULATION, ROUTACK, IN RODENT MODELS OF ANAPHYLAXIS

Anaphylaxis is a condition presenting with significant morbidity in sensitized individuals. IgE cross linking, degranulation of mast cells and release of preformed mediators are the pathophysiologic sequences responsib...

Download PDF file
  • EP ID EP113689
  • DOI -
  • Views 145
  • Downloads 0

How To Cite

Ruby Rohilla, Jitender Madan, Gaurav Kumar (2011). ADVANCEMENT IN TREATMENT TECHNOLOGY FOR UTERINE LEIOMYOMA. Pharma Science Monitor-An International Journal Pharmaceutical Sciences, 2(1), 1-17. https://europub.co.uk/articles/-A-113689